Go North Hemp Anticipates Significant Revenue Surge in 2025

Anticipating Revenue Growth at Go North Hemp
Go North Hemp, a prominent wholesale supplier of hemp-derived ingredients, has announced its ambitious projection for the year 2025: a remarkable 100% year-over-year revenue increase compared to 2024. This growth is attributed to the rising consumer demand for its innovative range of products, including EPN (Euphorinol), CBG, CBN, and CBD materials. These products are finding applications across various finished goods categories, establishing Go North Hemp as a key player in the hemp market.
Key Highlights for Growth
Several critical factors underpin Go North Hemp's optimistic outlook for 2025:
Doubling Revenue Expectations
The company anticipates achieving a 100% annual growth rate, driven by a robust order pipeline and increasing customer acceptance of their offerings, especially in ingestible and inhalable hemp products.
Showcasing at CHAMPS Austin
During the upcoming CHAMPS Austin event, taking place in September 2025, Go North Hemp plans to showcase its latest innovations. The company's focus will be on non-vaping products, particularly edibles and water-dispersible nano concentrates tailored for beverages and gummy products, in accordance with local regulations.
Formulation Efficiency
Go North Hemp's EPN, typically utilized at inclusion rates of 2-3%, is designed for efficient B2B development. This allows for smoother integration into various product lines without compromising the quality of formulations.
Solid Supply Readiness
The company is well-prepared to meet its buyers' needs with strong inventories of CBG Isolate, CBG Distillate, and its unique CBG Crystal-Resistant Distillate (CBG CRD).
Growth Trajectories
Go North Hemp's trajectory shows promising growth, with revenue expansion expected to continue at an impressive rate. This projection is a direct reflection of the momentum in the market as brands and distributors seek reliable, lab-verified hemp ingredients to integrate into their products.
Focus on Innovative Products
Part of the company’s strategy involves prioritizing innovative products like EPN and advanced CBG formats. EPN is extensively used in various adult-use products such as gummies and beverages, delivering high-quality outputs with minimal ingredient loadings. Furthermore, CBG CRD's features of flow stability and resistance to crystallization are enhancing its appeal for high-throughput manufacturing processes.
Event Engagement: Upcoming Trade Show
Go North Hemp is gearing up for significant engagement at the CHAMPS Trade Show. The company will connect with qualified buyers to discuss its extensive offerings in edibles, nano-emulsions for beverages, and new product introductions focused on non-vaping formats. This approach aligns with the company's strategy to foster consumer interest and expand its market reach.
Strategic Objectives for 2026
Looking ahead to 2026, Go North Hemp is poised to position CBG Crystal-Resistant Distillate as a flagship product. This initiative aims to attract brands that prioritize stable, versatile, and high-potency ingredients, allowing the company to maintain a diverse portfolio while paving the way for substantial growth.
Leadership Insights
CEO Greg Anthony emphasizes, "2025 is shaping up to be our most significant growth year. We're concentrating on reliability, documentation, and scalability, enabling our partners to formulate with confidence using EPN for performance or CBG CRD for stability." This forward-thinking approach is essential for fostering trust and reliability among stakeholders.
Commitment to Quality and Compliance
Go North Hemp's commitment to providing COA-backed, lab-tested ingredients is unwavering. The company continues to expand its production capacity while serving nutraceutical manufacturers and wellness brands across the nation. Additionally, they offer zero-THC specifications for clients operating in markets with stringent THC limits, subject to necessary validations.
About Go North Hemp
Go North Hemp is a U.S.-based wholesale supplier specializing in lab-verified, federally compliant, hemp-derived products. Their offerings include EPN (Euphorinol), CBG, CBN, and CBD, with a strong dedication to quality and dependable supply to processors, manufacturers, and retailers.
Frequently Asked Questions
What growth rate is Go North Hemp predicting for 2025?
Go North Hemp is predicting a remarkable 100% year-over-year growth in 2025.
What products will Go North Hemp feature at CHAMPS Austin?
At the CHAMPS Austin event, Go North Hemp will showcase edibles, nano concentrates for beverages, and new product offerings focused on non-vaping formats.
What makes EPN a preferred ingredient for formulations?
EPN's efficiency, typically used at 2-3% inclusion rates, enhances product development, allowing for high-quality finished goods without excessive loading.
How does Go North Hemp ensure compliance?
Go North Hemp provides COA-backed ingredients while expanding capacity to meet strict compliance requirements across various state markets.
What is the company's focus for 2026?
For 2026, Go North Hemp is prioritizing CBG Crystal-Resistant Distillate (CBG CRD) to appeal to brands seeking versatile and stable high-potency ingredients.
About The Author
Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.